Urgent care spending surges over 50% from 2018 to 2022, driven by increased visits, highlighting its vital role in healthcare access.

Although Medicaid expansion has been linked to lower mortality, significant racial disparities persist.

CMS announced 15 drugs for Medicare price negotiations under the IRA, representing $27 billion in spending and treating conditions such as diabetes, cancer, and autoimmune conditions. Here are three insights on the list from industry experts.

Chris Klomp, the director of Medicare and the deputy administrator at CMS, spoke about the proposed rule designed to curtail at-home risk assessments and other tactics that large insurers have used to game Medicare Advantage risk adjustment.

A new study has identified the brain connectivity patterns that lead to cognitive difficulties in patients with schizophrenia, suggesting potential targets for therapeutic intervention in early psychosis stages.

More Americans are tracking and changing their sleep habits, but the growing cultural focus on sleep data is also increasing anxiety, with orthosomnia leaving many people awake at night.

Proposed Medicare Advantage payment updates spark concern among insurers and investors, raising questions about risk adjustment and potential impacts on beneficiaries.

During an investor call, UnitedHealth Group executives talk about the steps it has taken to increase transparency, use technology to reshape its healthcare delivery and address how it adapting to financial pressures across its Medicare, Medicaid, and Affordable Care Act businesses.

Lung cancer remains the leading cause of cancer deaths in the U.S. in 2026 and is expected to account for an estimated 229,410 new cases.